loading page

Death due to Covid-19 in a Patient with Diabetes, Epilepsy, and Gout comorbidities
  • +2
  • Amir Reza Safdarian,
  • Kaveh Momenzadeh,
  • Farima Kahe,
  • Pooya Farhangnia,
  • nima rezaei
Amir Reza Safdarian
Alborz University of Medical Sciences
Author Profile
Kaveh Momenzadeh
Beth Israel Deaconess Medical Center
Author Profile
Farima Kahe
Beth Israel Deaconess Medical Center
Author Profile
Pooya Farhangnia
Iran University of Medical Sciences
Author Profile
nima rezaei
Tehran University of Medical Sciences
Author Profile

Abstract

There is evidence of increased incidence, rapid progression, and poor prognosis of Covid-19 in patients with underlying comorbidities such as diabetes and epilepsy. It is crucial to develop effective treatment regimens for these patients. Multiple organ failure is the most common cause of death in Covid-19 patients.

Peer review status:Published

16 Sep 2020Submitted to Clinical Case Reports
19 Sep 2020Submission Checks Completed
19 Sep 2020Assigned to Editor
06 Oct 2020Reviewer(s) Assigned
13 Oct 2020Review(s) Completed, Editorial Evaluation Pending
16 Oct 2020Editorial Decision: Revise Minor
21 Oct 20201st Revision Received
22 Oct 2020Submission Checks Completed
22 Oct 2020Assigned to Editor
22 Oct 2020Review(s) Completed, Editorial Evaluation Pending
01 Nov 2020Editorial Decision: Accept
Jan 2021Published in Clinical Case Reports volume 9 issue 1 on pages 461-464. 10.1002/ccr3.3557